Article
Evaluation of Humoral and Cellular Immune Responses to the SARS-CoV-2 Vaccine in Patients With Common Variable Immunodeficiency Phenotype and Patient Receiving B-Cell Depletion Therapy.
Frontiers in immunology - 1 Jan 2022
Antolí Arnau, Rocamora-Blanch Gemma, Framil Mario, Mas-Bosch Virgínia, Navarro Sergio, Bermudez Carla, Martinez-Yelamos Sergio, Dopico Eva, Calatayud Laura, Garcia-Muñoz Nadia, Hernández-Benítez Luis Humberto, Riera-Mestre Antoni, Bas Jordi, Masuet-Aumatell Cristina, Rigo-Bonnin Raúl, Morandeira Francisco, Solanich Xavier
Abstract excerpt
Introduction: SARS-CoV-2 vaccines' effectiveness is not yet clearly known in immunocompromised patients. This study aims to assess the humoral and cellular specific immune response to SARS-CoV-2 vaccines and the predictors of poor response in patients with common variable immunodeficiency (CVID) phenotype and in patients treated with B-cell depletion therapies (BCDT), as well as the safety of these vaccines....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
